CYTARABINE

Course overview

CYTARABINE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF LEUKEMIAS AND LYMPHOMAS. IT BELONGS TO THE ANTIMETABOLIC GROUP OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CYTARABINE AS A VALUABLE AGENT IN TREATING ACUTE MYELOID LEUKEMIA (AND OTHER LEUKEMIAS). THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH LEUKEMIA AND RELATED CONDITIONS.